Oral Ivermectin

DRUG3 trials

Sponsors

University of Oxford, Sohaib Ashraf, Phramongkutklao College of Medicine and Hospital

Conditions

COVIDCoronavirus InfectionDimethicone Adverse ReactionDimethicone AllergyIvermectinPediculus Capitis InfestationPermethrin Adverse ReactionPermethrin Allergy

Phase 1

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Sohaib AshrafCoronavirus Infection, COVID, Sars-CoV2

Start: 2020-11-14End: 2021-10-30Target: 180Updated: 2021-02-17

Phase 2

Ivermectin Safety in Small Children

CompletedNCT04332068

University of OxfordScabies

Start: 2023-11-18End: 2025-04-04Updated: 2025-12-18

Phase 4

Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand

Active, not recruitingNCT06332872

Phramongkutklao College of Medicine and HospitalDimethicone Adverse Reaction, Dimethicone Allergy, Ivermectin +4

Start: 2023-12-15End: 2024-05-31Target: 117Updated: 2024-03-27

Related Papers

Comparative Effectiveness of Oral Ivermectin, 1% Permethrin Shampoo, and 4% Dimethicone Liquid Gel in Treatment of Pediculosis Capitis among School Children in Chachoengsao Province, Thailand

American Journal of Tropical Medicine and Hygiene2026-07-21

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.

2021-09-063 citations